Summary
Revenue for the June 2018 quarter reached $3.76 million, up 47.9% from the prior-year quarter. Higher biometrics license, maintenance and services sales drove the gain. Profitability moved the other way. The company swung to an operating loss of $0.38 million, a decline of $0.44 million from the operating income reported a year earlier. Net loss was $0.19 million, down $0.30 million. Diluted EPS was -$0.01, down $0.02. Operating margin fell to -10.1%, down 12.7 percentage points. Management attributed the swing to the absence of income from a patent arrangement and to higher total engineering costs. Royalties dropped to zero from $41,000 in the prior-year quarter, and management does not treat DSL royalties as a key part of the strategy.
The first half of 2018 looks different on the top line. Revenue for the six months ended June 30, 2018 was $6.67 million, flat against the prior-year period, a decrease of 0.4%. The company reported an operating loss of $1.10 million for the six months, a decline of $1.39 million. Net loss was $0.68 million, down $1.10 million. Diluted EPS was -$0.03, down $0.05. Operating margin was -16.5%, down 20.8 percentage points. The same two items, no patent income and higher engineering costs, drove most of the deterioration, although a lower cost of software licenses offset part of it.
Operational detail shows where the quarter's growth came from. Software license revenue rose 64% and services revenue rose 239%, while software maintenance revenue rose 9%. Software license revenue was 44% of total revenue in the quarter, up from 40% a year earlier. Services rose to 19% of total revenue from 8%, and maintenance slipped to 37% from 50%. A software license agreement with a systems integrator signed in the second quarter supplied the bulk of the license and services improvement. Management expects development work on that project to continue for roughly the next three to four quarters. Services backlog was $1.5 million at June 30, 2018. Over the six months, software license revenue fell 10% because a $0.9 million software license sale to the U.S. Marines in the first half of 2017 did not repeat, and management cannot predict whether that customer will buy the software again.
Costs and cash use deserve attention. Total engineering costs rose in both periods. Research and development expense was essentially unchanged. Sales and marketing expense rose 2% and general and administrative expense rose 7%, mostly on higher professional fees. Interest income rose 127% in the quarter and 111% for the six months on higher money market rates. Income tax expense was $8,000 for the quarter, while the six months produced a tax benefit of $58,000. Operating cash flow was -$1.38 million in the quarter and -$2.18 million for the six months, a decline of $2.45 million from the prior-year period. Capital expenditures were $0.04 million in the quarter, down 20.8%, and $0.13 million for the six months, up 152.8%. Cash and cash equivalents were $49.1 million at June 30, 2018, a decrease of $2.5 million from December 31, 2017. Deferred revenue stood at $2.42 million. The largest first-half cash uses were operations, $137,000 of stock buybacks and $61,000 of tax payments on stock grants, partly offset by $27,000 of employee stock purchase proceeds. Management says cash and cash equivalents will fund operations for at least the next twelve months.
Risks centre on concentration and timing. Revenue depends on a small number of large government and integrator projects, and the missing USMC order shows how lumpy that can be. Patent monetization income is unpredictable. The DSL royalty stream has ended, and management does not expect it to return. Commercial biometrics remains an emerging market, and management says it cannot predict revenue from it. The company also holds $5.2 million of deferred tax assets with no valuation allowance, a judgment it reviews each period. With an operating loss and negative operating cash flow in the first half, the near-term case rests on turning the integrator project into follow-on work and on keeping engineering spending in check.
Forecast
No forward guidance in this quarter's filings.
Reported figures
GAAP, from SEC filings| Metric | Q2 FY2018 | Q1 FY2018 | QoQ | Q2 FY2017 | YoY |
|---|---|---|---|---|---|
| Revenue | $3.8M | $144.0K | +2511.1% | $206.0K | +1725.2% |
| Research & development | $1.9M | $1.9M | +0.6% | $1.9M | +0.6% |
| Sales & marketing | $1.0M | $924.0K | +9.6% | $1.0M | -1.1% |
| General & administrative | $871.0K | $785.0K | +11.0% | $816.0K | +6.7% |
| Total operating expenses | $4.1M | $3.6M | +14.0% | $3.8M | +8.4% |
| Operating income (loss) | -$381.0K | -$723.0K | +47.3% | $238.0K | -260.1% |
| Operating margin | -10.1% | -502.1% | +491.9 pp | 115.5% | -125.7 pp |
| Net income (loss) | -$188.0K | -$495.0K | +62.0% | $228.0K | -182.5% |
| Net margin | -5.0% | -343.8% | +338.8 pp | 110.7% | -115.7 pp |
| Diluted EPS | -$0.01 | -$0.02 | +$0.01 | $0.01 | -$0.02 |
Risks
A software license agreement with a systems integrator for a large project contributed $0.6 million of software license revenue in the second quarter of 2018 and the first six months of 2018. The company expects development effort on this project to continue for approximately the next three to four quarters, making revenue and cost of services dependent on this single project.
No income from the patent arrangement was recorded in the three and six months ended June 30, 2018, compared with $1.3 million and $1.4 million in the prior-year periods. The company cannot predict how much more income it might receive, if any, because patent monetization efforts by the third party may not be successful.
The company swung to an operating loss of $0.4 million in the second quarter of 2018 from operating income of $0.1 million in the prior-year quarter, and to a net loss of $0.2 million from net income of $0.1 million. Operating margin declined to -10.1% in the quarter from 2.5% in the prior-year quarter.
Biometrics software license sales decreased $0.6 million in the first six months of 2018 versus the prior-year period, mainly because a $0.9 million software license sale to the U.S. Marines in the first six months of 2017 did not repeat. The company states it is unable to predict whether the USMC will purchase this software again in the future.
As of June 30, 2018, the company had $5.2 million of deferred tax assets with no valuation allowance. It will continue to assess the level of valuation allowance, and if evidence regarding realizability changes, the allowance will be adjusted accordingly.
SaaS KPIs
All quarters →Services Backlog
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q2 FY2018 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Nov 9, 2026.